Biophytis (EPA:ALBPS) | WebDisclosure

BRIEF

published on 12/02/2024 at 07:05, 19 days 8 hours ago

Biophytis Engages in SCWD Congress and Hosts Obesity Investor Call

Biophytis Investor Call Obesity Treatment GLP-1 RA SCWD Congress
BRIEF

published on 12/02/2024 at 07:05, 19 days 8 hours ago

Biophytis au congrès SCWD et organise un Obesity Investor Call

Biophytis Obésité Investisseur Congrès SCWD GLP-1 RA
REGULATED PRESS RELEASE

published on 12/02/2024 at 07:00, 19 days 9 hours ago

Biophytis participates in the 17th SCWD Congress and hosts an Obesity Investor Call
Biophytis announces participation in the 17th SCWD Congress and hosting an Obesity Investor Call. Key opinion leaders to discuss GLP-1 RA therapy. Event on December 6, 2024

Biophytis Clinical Research Obesity Investor Call SCWD Congress GLP-1 RA Therapy
REGULATED PRESS RELEASE

published on 12/02/2024 at 07:00, 19 days 9 hours ago

Biophytis participe à la 17ème édition du congrès SCWD et organise un Obesity Investor Call
Biophytis participe à la 17ème édition du congrès SCWD et organise un Obesity Investor Call pour discuter des implications cliniques des traitements GLP-1 RA dans l'obésité

Biophytis Maladies Liées À L'âge GLP-1 RA 17ème Édition Obesity Investor Call
BRIEF

published on 09/30/2024 at 23:05, 2 months 20 days ago

Biophytis Reports First-Half Financial Results and Updates on Business Activities

Financial Results Biophytis Clinical Trials Obesity Treatment Partnerships
BRIEF

published on 09/30/2024 at 23:05, 2 months 20 days ago

Biophytis publie ses comptes semestriels et annonce des avancées stratégiques

Biophytis Financement Finances 2024 Programme OBA Accord Blanver
PRESS RELEASE

published on 09/30/2024 at 23:00, 2 months 20 days ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and business activities update, including launch of obesity program and licensing agreement with Blanver for Latin America, with a focus on key achievements and financial highlights

Financial Results Biophytis Licensing Agreement Business Activities Obesity Program
PRESS RELEASE

published on 09/30/2024 at 23:00, 2 months 20 days ago

Biophytis publie ses comptes semestriels et fait le point sur ses activités
Biophytis publie ses comptes semestriels et fait le point sur ses activités. La société présente ses résultats financiers pour le premier semestre 2024 et annonce les prochaines étapes de développement de ses programmes cliniques

Biophytis Partenariat BIO101 Obésité Comptes Semestriels
REGULATED PRESS RELEASE

published on 09/30/2024 at 23:00, 2 months 20 days ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and updates on business activities, highlighting key achievements including launch of OBA program for obesity with BIO101 and exclusive licensing agreement with Blanver for Latin America

Financial Results Biophytis Latin America BIO101 OBA Program
REGULATED PRESS RELEASE

published on 09/30/2024 at 23:00, 2 months 20 days ago

Biophytis publie ses comptes semestriels et fait le point sur ses activités
Biophytis publie ses résultats semestriels 2024, annonce son programme OBA dans l'obésité et un accord avec Blanver pour l'Amérique Latine

Résultats Semestriels Biophytis Biotechnologie Programme OBA Accord Blanver

Published on 12/21/2024 at 01:30, 14 hours 32 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 14 hours 32 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 15 hours 57 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 16 hours 2 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 16 hours 32 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 15 hours 11 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 15 hours 17 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 20 hours 52 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 21 hours 6 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 22 hours 2 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 3 hours 44 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 3 hours 44 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 22 hours 2 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 22 hours 2 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 22 hours 7 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News